Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005681 | spliceosomal complex | 3 | 12 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0140513 | nuclear protein-containing complex | 2 | 12 |
GO:1990904 | ribonucleoprotein complex | 2 | 12 |
Related structures:
AlphaFold database: A4HTQ1
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 12 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 12 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 12 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006397 | mRNA processing | 7 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0008380 | RNA splicing | 7 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0016071 | mRNA metabolic process | 6 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000386 | second spliceosomal transesterification activity | 4 | 12 |
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0030628 | pre-mRNA 3'-splice site binding | 6 | 12 |
GO:0036002 | pre-mRNA binding | 5 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0008270 | zinc ion binding | 6 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
GO:0046914 | transition metal ion binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 214 | 218 | PF00656 | 0.558 |
CLV_NRD_NRD_1 | 26 | 28 | PF00675 | 0.407 |
CLV_NRD_NRD_1 | 281 | 283 | PF00675 | 0.503 |
CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.547 |
CLV_PCSK_KEX2_1 | 150 | 152 | PF00082 | 0.450 |
CLV_PCSK_KEX2_1 | 281 | 283 | PF00082 | 0.480 |
CLV_PCSK_KEX2_1 | 403 | 405 | PF00082 | 0.384 |
CLV_PCSK_PC1ET2_1 | 150 | 152 | PF00082 | 0.442 |
CLV_PCSK_PC1ET2_1 | 403 | 405 | PF00082 | 0.410 |
CLV_PCSK_SKI1_1 | 14 | 18 | PF00082 | 0.567 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.419 |
CLV_PCSK_SKI1_1 | 304 | 308 | PF00082 | 0.675 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.716 |
DEG_SPOP_SBC_1 | 331 | 335 | PF00917 | 0.755 |
DEG_SPOP_SBC_1 | 342 | 346 | PF00917 | 0.695 |
DOC_AGCK_PIF_2 | 271 | 276 | PF00069 | 0.536 |
DOC_CYCLIN_yClb3_PxF_3 | 46 | 54 | PF00134 | 0.526 |
DOC_MAPK_DCC_7 | 27 | 36 | PF00069 | 0.397 |
DOC_MAPK_gen_1 | 150 | 160 | PF00069 | 0.527 |
DOC_MAPK_MEF2A_6 | 153 | 162 | PF00069 | 0.536 |
DOC_PP4_FxxP_1 | 220 | 223 | PF00568 | 0.466 |
DOC_USP7_MATH_1 | 234 | 238 | PF00917 | 0.433 |
DOC_USP7_MATH_1 | 363 | 367 | PF00917 | 0.607 |
DOC_USP7_MATH_1 | 410 | 414 | PF00917 | 0.443 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.677 |
DOC_USP7_UBL2_3 | 204 | 208 | PF12436 | 0.449 |
DOC_USP7_UBL2_3 | 403 | 407 | PF12436 | 0.462 |
DOC_WW_Pin1_4 | 306 | 311 | PF00397 | 0.552 |
DOC_WW_Pin1_4 | 343 | 348 | PF00397 | 0.703 |
DOC_WW_Pin1_4 | 42 | 47 | PF00397 | 0.398 |
LIG_14-3-3_CanoR_1 | 111 | 119 | PF00244 | 0.417 |
LIG_BIR_III_4 | 408 | 412 | PF00653 | 0.395 |
LIG_BRCT_BRCA1_1 | 115 | 119 | PF00533 | 0.477 |
LIG_BRCT_BRCA1_1 | 267 | 271 | PF00533 | 0.445 |
LIG_FHA_1 | 128 | 134 | PF00498 | 0.509 |
LIG_FHA_1 | 301 | 307 | PF00498 | 0.701 |
LIG_FHA_1 | 357 | 363 | PF00498 | 0.642 |
LIG_FHA_2 | 132 | 138 | PF00498 | 0.439 |
LIG_FHA_2 | 307 | 313 | PF00498 | 0.458 |
LIG_FHA_2 | 38 | 44 | PF00498 | 0.461 |
LIG_Integrin_RGD_1 | 242 | 244 | PF01839 | 0.416 |
LIG_LIR_Apic_2 | 217 | 223 | PF02991 | 0.513 |
LIG_LIR_Apic_2 | 388 | 392 | PF02991 | 0.475 |
LIG_LIR_Gen_1 | 252 | 261 | PF02991 | 0.405 |
LIG_LIR_Gen_1 | 268 | 279 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 250 | 256 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 258 | 264 | PF02991 | 0.391 |
LIG_LIR_Nem_3 | 268 | 274 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 388 | 393 | PF02991 | 0.454 |
LIG_PDZ_Class_1 | 412 | 417 | PF00595 | 0.589 |
LIG_SH2_CRK | 261 | 265 | PF00017 | 0.499 |
LIG_SH2_GRB2like | 129 | 132 | PF00017 | 0.554 |
LIG_SH2_GRB2like | 253 | 256 | PF00017 | 0.495 |
LIG_SH2_SRC | 256 | 259 | PF00017 | 0.524 |
LIG_SH2_STAP1 | 129 | 133 | PF00017 | 0.543 |
LIG_SH2_STAT5 | 129 | 132 | PF00017 | 0.554 |
LIG_SH2_STAT5 | 209 | 212 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 256 | 259 | PF00017 | 0.429 |
LIG_SH2_STAT5 | 389 | 392 | PF00017 | 0.349 |
LIG_SH3_3 | 174 | 180 | PF00018 | 0.603 |
LIG_SH3_3 | 344 | 350 | PF00018 | 0.601 |
LIG_SH3_3 | 43 | 49 | PF00018 | 0.414 |
LIG_SUMO_SIM_par_1 | 32 | 40 | PF11976 | 0.399 |
LIG_TRAF2_1 | 140 | 143 | PF00917 | 0.551 |
LIG_TRAF2_1 | 40 | 43 | PF00917 | 0.447 |
LIG_TRFH_1 | 29 | 33 | PF08558 | 0.403 |
MOD_CK1_1 | 127 | 133 | PF00069 | 0.526 |
MOD_CK1_1 | 333 | 339 | PF00069 | 0.636 |
MOD_CK1_1 | 341 | 347 | PF00069 | 0.608 |
MOD_CK1_1 | 374 | 380 | PF00069 | 0.535 |
MOD_CK1_1 | 98 | 104 | PF00069 | 0.460 |
MOD_CK2_1 | 133 | 139 | PF00069 | 0.537 |
MOD_CK2_1 | 331 | 337 | PF00069 | 0.633 |
MOD_CK2_1 | 37 | 43 | PF00069 | 0.415 |
MOD_GlcNHglycan | 340 | 343 | PF01048 | 0.660 |
MOD_GlcNHglycan | 412 | 415 | PF01048 | 0.555 |
MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.655 |
MOD_GSK3_1 | 109 | 116 | PF00069 | 0.451 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.327 |
MOD_GSK3_1 | 300 | 307 | PF00069 | 0.642 |
MOD_GSK3_1 | 314 | 321 | PF00069 | 0.425 |
MOD_GSK3_1 | 331 | 338 | PF00069 | 0.591 |
MOD_GSK3_1 | 354 | 361 | PF00069 | 0.662 |
MOD_GSK3_1 | 371 | 378 | PF00069 | 0.574 |
MOD_NEK2_1 | 314 | 319 | PF00069 | 0.445 |
MOD_NEK2_1 | 354 | 359 | PF00069 | 0.675 |
MOD_NEK2_2 | 95 | 100 | PF00069 | 0.317 |
MOD_PIKK_1 | 145 | 151 | PF00454 | 0.510 |
MOD_PIKK_1 | 256 | 262 | PF00454 | 0.516 |
MOD_PIKK_1 | 319 | 325 | PF00454 | 0.642 |
MOD_PK_1 | 124 | 130 | PF00069 | 0.518 |
MOD_PK_1 | 9 | 15 | PF00069 | 0.606 |
MOD_PKA_1 | 9 | 15 | PF00069 | 0.562 |
MOD_PKA_2 | 131 | 137 | PF00069 | 0.517 |
MOD_Plk_1 | 171 | 177 | PF00069 | 0.458 |
MOD_Plk_2-3 | 171 | 177 | PF00069 | 0.458 |
MOD_Plk_4 | 124 | 130 | PF00069 | 0.518 |
MOD_Plk_4 | 371 | 377 | PF00069 | 0.601 |
MOD_Plk_4 | 385 | 391 | PF00069 | 0.314 |
MOD_Plk_4 | 62 | 68 | PF00069 | 0.507 |
MOD_ProDKin_1 | 306 | 312 | PF00069 | 0.549 |
MOD_ProDKin_1 | 343 | 349 | PF00069 | 0.698 |
MOD_ProDKin_1 | 42 | 48 | PF00069 | 0.395 |
MOD_SUMO_rev_2 | 137 | 146 | PF00179 | 0.558 |
MOD_SUMO_rev_2 | 2 | 11 | PF00179 | 0.575 |
MOD_SUMO_rev_2 | 217 | 225 | PF00179 | 0.442 |
MOD_SUMO_rev_2 | 333 | 341 | PF00179 | 0.680 |
MOD_SUMO_rev_2 | 80 | 88 | PF00179 | 0.608 |
TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.413 |
TRG_ENDOCYTIC_2 | 261 | 264 | PF00928 | 0.393 |
TRG_ER_diArg_1 | 184 | 187 | PF00400 | 0.613 |
TRG_ER_diArg_1 | 280 | 282 | PF00400 | 0.566 |
TRG_Pf-PMV_PEXEL_1 | 14 | 19 | PF00026 | 0.453 |
TRG_Pf-PMV_PEXEL_1 | 21 | 25 | PF00026 | 0.359 |
TRG_Pf-PMV_PEXEL_1 | 262 | 267 | PF00026 | 0.377 |
TRG_Pf-PMV_PEXEL_1 | 304 | 308 | PF00026 | 0.596 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PD09 | Leptomonas seymouri | 68% | 98% |
A0A0S4IP46 | Bodo saltans | 36% | 97% |
A0A1X0NEY6 | Trypanosomatidae | 48% | 92% |
A0A3R7NLB9 | Trypanosoma rangeli | 45% | 98% |
A0A3S5H692 | Leishmania donovani | 100% | 100% |
A4H5F6 | Leishmania braziliensis | 82% | 100% |
C9ZPF5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 87% |
E9AMI8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
O95391 | Homo sapiens | 26% | 71% |
P0CR52 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 27% | 73% |
P0CR53 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 27% | 73% |
Q3KQD1 | Xenopus laevis | 28% | 72% |
Q3ZBE5 | Bos taurus | 26% | 71% |
Q4QI51 | Leishmania major | 96% | 100% |
Q4R4P2 | Macaca fascicularis | 26% | 71% |
Q4WWR2 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 25% | 88% |
Q51LA6 | Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) | 23% | 88% |
Q54TA0 | Dictyostelium discoideum | 27% | 75% |
Q5B3U2 | Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) | 25% | 89% |
Q5U3F2 | Danio rerio | 28% | 73% |
Q5ZIG2 | Gallus gallus | 27% | 74% |
Q7SDY6 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 23% | 100% |
Q80ZG5 | Rattus norvegicus | 27% | 71% |
Q8BHJ9 | Mus musculus | 26% | 71% |
Q9SHY8 | Arabidopsis thaliana | 26% | 78% |
Q9VAQ7 | Drosophila melanogaster | 35% | 73% |
V5DAD7 | Trypanosoma cruzi | 46% | 90% |